Asciminib
Asciminib, sold under the brand name Scemblix, is a medication used to treat Philadelphia chromosome-positive chronic myeloid leukemia. It is a protein kinase inhibitor. Reference standards of Asciminib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Asciminib - API Standards
[catalogue_number] => PA 01 3630000
[category_ids] => ,76,78,70,82,
[chemical_name] =>
[weight] => 449.84
[form] => C20H18ClF2N5O3
[cas] => 1492952-76-7
[pslug] => 1492952-76-7-asciminib-api-pa013630000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Asciminib - API Standards
Catalogue No.:PA 01 3630000
Molecular Formula : C20H18ClF2N5O3
Molecular Weight : 449.84
stdClass Object
(
[pname] => (R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-N-nitroso-5-(1H-pyrazol-3-yl)nicotinamide
[catalogue_number] => PA 01 3631000
[category_ids] => ,76,78,70,82,162,
[chemical_name] =>
[weight] => 478.84
[form] => C20H17ClF2N6O4
[cas] => NA
[pslug] => r-n-4-chlorodifluoromethoxy-phenyl-6-3-hydroxypyrrolidin-1-yl-n-nitroso-5-1h-pyrazol-3-yl-nicotinamide-pa013631000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-N-nitroso-5-(1H-pyrazol-3-yl)nicotinamide
Catalogue No.:PA 01 3631000
Molecular Formula : C20H17ClF2N6O4
Molecular Weight : 478.84